<DOC>
	<DOCNO>NCT01606306</DOCNO>
	<brief_summary>The INFANT study test whether , preschool child 12-59 month age persistent asthma , follow Step 2 asthma therapy provide similar degree asthma control : 1 . Daily inhale corticosteroid ( ICS ) treatment , 2 . Daily leukotriene receptor antagonist ( LTRA ) treatment , 3 . As-needed ICS plus short-acting beta agonist ( as-needed ICS/SABA ) rescue treatment .</brief_summary>
	<brief_title>Individualized Therapy For Asthma Toddlers</brief_title>
	<detailed_description>INFANT double-blind , randomize clinical trial participant receive three therapy 16 week mean cross-over study design . INFANT aim determine whether individual child respond good one treatment another , , whether child identify phenotypic characteristic select biomarkers . In regard INFANT study expect address critical gap current asthma management guideline . Ultimately , finding study expect help clarify treatment modality population young preschool child extremely difficult treat .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Respiratory Sounds</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>1259 month age . If child currently take longterm asthma controller therapy ( mean child take inhaled corticosteroid leukotriene receptor antagonist medication whatsoever past 6 month ) , one follow criterion must meet : Daytime asthma symptom two day per week ( average past 4 week ) , At least one nighttime awaken asthma ( past 4 week ) , Two asthma exacerbation require systemic corticosteroid previous 6 month , Four wheeze episode previous 12 month . If child currently take longterm asthma controller therapy ( mean child take daily intermittent/asneeded inhale corticosteroid leukotriene receptor antagonist past 6 month ) , one follow criterion must meet : Taking inhale corticosteroid leukotriene receptor antagonist 3 month ( 90 day ) previous 6 month ( 180 day ) , Daytime asthma symptom two day per week ( average past 4 week ) , More one nighttime awaken asthma ( past 4 week ) , Two asthma exacerbation require systemic corticosteroid previous 12 month , Four wheeze episode previous 12 month . Up date immunization , include varicella ( unless subject already clinical varicella ) . Willingness provide informed consent child 's parent guardian . Allergic reaction study medication component study drug , include ( limited ) urticaria , rash , angioedema , hypotension follow delivery , Chronic medical disorder could interfere drug metabolism/excretion ( instance chronic hepatic , biliary , renal disease ) , Chronic medical disorder may increase risk drugrelated injury , include ( limited ) : Osteogenesis imperfecta ( increase risk bone demineralization/fracture corticosteroid therapy ) , Crohn 's disease , ulcerative colitis , juvenile rheumatoid arthritis , clot disorder , Factor deficiency ( increase risk bleed corticosteroid therapy ) , G6PD deficiency ( increase risk hemolytic anemia acetaminophen use ) , Phenylketonuria ( potential aspartame exposure study intervention ) , Seizure disorder treat anticonvulsant ( risk acetaminophen toxicity carbamazepine ) , History clot disorder Factor deficiency ( increase risk bleed corticosteroid ) , Comorbid disorder associate wheeze include ( limited ) immune deficiency disorder , cystic fibrosis , aspiration , clinicallyrelevant gastroesophageal reflux , tracheomalacia , congenital airway anomaly ( cleft , fistula , sling , ring ) , bronchiectasis , bronchopulmonary dysplasia , and/or history premature birth 35 week gestation , Significant developmental delay/failure thrive , define 5th percentile height and/or weight cross two major percentile line last year age sex , History nearfatal asthma exacerbation require intubation assist ventilation , No primary medical caregiver ( e.g. , nurse practitioner , physician assistant , physician , group medical practice hospitalbased clinic ) subject contact primary medical care , Three hospitalization previous 12 month wheeze respiratory illness , Treatment 5 course systemic corticosteroid ( oral , intramuscular intravenous ) past 6 month , Current use high step 2 NAEPP asthma guideline therapy If receive allergy shot , change dose within past 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>59 Months</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Wheezing</keyword>
	<keyword>Fluticasone</keyword>
	<keyword>Montelukast</keyword>
	<keyword>Preschool-age</keyword>
</DOC>